Parkinson hastalığında tedavi stratejilerinin değişimi için klinik kriterler.
Clinical criteria for the switch of treatment strategies in Parkinson's disease.
DOI: 10.1016/s0303-8467(03)00036-2PMID: 12954538
Clinical criteria for the switch of treatment strategies in Parkinson's disease.
DOI: 10.1016/s0303-8467(03)00036-2PMID: 12954538
Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
DOI: 10.1016/s0014-4886(03)00184-5PMID: 12957481
Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.
DOI: 10.1016/s0014-4886(03)00107-9PMID: 12957489
Recognition and treatment of depression in Parkinson's disease.
DOI: 10.1177/0891988703256053PMID: 12967062
Causes and prognosis of cardiac arrest in a population admitted to a general hospital; a diagnostic and therapeutic problem.
DOI: 10.1016/s0300-9572(03)00154-0PMID: 12969610
The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data.
DOI: 10.1097/00146965-200309000-00005PMID: 14501539
Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease.
DOI: 10.1002/mds.10481PMID: 14502666
Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
DOI: 10.1002/mds.10494PMID: 14502668
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
DOI: 10.1002/mds.10566PMID: 14502659
Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study.
DOI: 10.1016/s0278-5846(03)00156-8PMID: 14499313
[Cellular therapy in neurodegenerative diseases: perspective from the experimental model of Parkinson's disease].
PMID: 14505242
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias.
DOI: 10.1046/j.1460-9568.2003.02896.xPMID: 14511339
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.